July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today ...
July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 20, 2023 — The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume ...
July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...
July 20, 2023 — A new expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) offers clinical ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 20, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) is preparing for its 18th Annual Scientific ...
The U.S. organ donation system has long been under scrutiny, with questions about fairness in organ allocation and ...
July 19, 2023 — The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...
July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...
July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...
July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire ...
July 21, 2023
